E-mail Updates- Home
- Slides
- Home
- Tools and Resources
- Research Summaries for Consumers, Clinicians, and Policymakers
- Search for Research Summaries, Reviews, and Reports
- Research Available for Comment
- Submit a Suggestion for Research
- Submit Scientific Information Packets
- Comparative Effectiveness Research Grant and ARRA Awards
- News and Announcements
- What Is Comparative Effectiveness Research
- Who Is Involved in the Effective Health Care Program
- What Is the Effective Health Care Program
Slides
Slides: 1–12 of 30
Background: Diagnosis of Obstructive Sleep Apnea (2 of 3)
Keywords: background | diagnosis | polysomnography | monitor | sleep study | questionnaire | clinical prediction rules
Effectiveness of Questionnaires and Clinical Prediction Rules
Keywords: clinical prediction rules | detection | diagnosis | monitor | polysomnography | questionnaires | screening | strength of evidence | outcomes
Other Outcomes of Interest (1 of 2)
Keywords: outcome | strength of evidence | compliance | questionnaire | mandibular advancement device | MAD | continuous positive airway pressure | CPAP | apnea-hypopnea index | AHI | surgery | treatment | oral device
Other Outcomes of Interest (2 of 2)
Keywords: outcome | strength of evidence | compliance | questionnaire | mandibular advancement device | MAD | continuous positive airway pressure | CPAP | apnea-hypopnea index | AHI | surgery | treatment | oral device
Conclusions (1 of 2)
Keywords: conclusions | take-home messages | main points | apnea-hypopnea index | AHI | monitor | continuous positive airway pressure | CPAP | mandibular advancement device | MAD | weight-loss program | diagnosis | screening | treatment
Clinically Significant Outcomes of Interest (2 of 2)
Evaluating JIA Assessment Instruments (1 of 3)
Keywords: active joint count | anti-rheumatic | antirheumatic | assessment | biologic DMARD | CHAQ | CHQ | disease-modifying | DMARDs | JCA | JIA | JRA | juvenile rheumatoid arthritis | non-biologic DMARD | nonbiologic DMARD | parent global assessment of well-being | PedsQL | PedsQL-RM | physician global assessment | reliability | responsiveness | rheumatic | TNF-alpha blockers | validity | juvenile idiopathic arthritis
Results From Evaluation of JIA Assessment Instruments (1 of 2)
Keywords: active joint count | AJC | anti-rheumatic | antirheumatic | assessment | biologic DMARD | disease-modifying | DMARDs | JCA | JIA | JRA | juvenile rheumatoid arthritis | non-biologic DMARD | nonbiologic DMARD | parent assessment of well-being | PGA | PGW | physician global assessment | reliability | responsiveness | rheumatic | TNF-alpha blockers | validity | juvenile idiopathic arthritis
Results From Evaluation of JIA Assessment Instruments (2 of 2)
Keywords: juvenile idiopathic arthritis | JIA | JRA | juvenile rheumatoid arthritis | JCA | DMARDs | disease-modifying | antirheumatic | anti-rheumatic | rheumatic | TNF-alpha blockers | biologic DMARD | nonbiologic DMARD | non-biologic DMARD | assessment | validity | reliability | responsiveness | active joint count | physician global assessment | parent assessment of well-being | AJC | PGA | PGW | CHAQ | CHq | PedsQL | PedsQl-RM
Evaluating JIA Assessment Instruments: Conclusions (1 of 2)
Keywords: juvenile idiopathic arthritis | JIA | JRA | juvenile rheumatoid arthritis | JCA | DMARDs | disease-modifying | antirheumatic | anti-rheumatic | rheumatic | TNF-alpha blockers | biologic DMARD | nonbiologic DMARD | non-biologic DMARD | assessment | validity | reliability | responsiveness | CHAQ
Clinically Significant Outcomes of Interest in the Comparative Effectiveness Review
Presentation: Drug Therapy for Rheumatoid Arthritis in Adults
Keywords: rheumatoid arthritis | RA | DMARDs | disease-modifying | antirheumatic | anti-rheumatic | rheumatic | biologic | oral | disease activity | ACR | radiographic evidence of progression | functional capacity | HAQ | quality of life | SF-36 | DAS
Analytic Methods Used in the Systematic Review
Presentation: Drug Therapy for Rheumatoid Arthritis in Adults
Keywords: rheumatoid arthritis | RA | DMARDs | disease-modifying | antirheumatic | anti-rheumatic | rheumatic | biologic | oral | ACR20 | disease activity | functional ability | HAQ | Health Assessment Questionnaire | health-related quality of life | SF-36 | Sharp/van de Heijde | joint damage
Your slide tray is being processed.
